Ownership history in BRAIDWELL LP · 7 quarters on record
This page tracks every 13F SEC filing in which BRAIDWELL LP reported a position in VIKING THERAPEUTICS INC (VKTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 759,455 | -678,100 | -47.2% | 0.59% | $20.0M | $26.28 |
| 2025 Q2 | ADDED | 1,437,555 | +1,600 | +0.1% | 1.30% | $38.1M | $26.50 |
| 2025 Q1 | REDUCED | 1,435,955 | -43,711 | -3.0% | 1.22% | $34.7M | $24.15 |
| 2024 Q4 | ADDED | 1,479,666 | +322,689 | +27.9% | 1.77% | $59.5M | $40.24 |
| 2024 Q3 | ADDED | 1,156,977 | +50,072 | +4.5% | 2.08% | $73.2M | $63.31 |
| 2024 Q2 | ADDED | 1,106,905 | +393,805 | +55.2% | 1.84% | $58.7M | $53.01 |
| 2024 Q1 | INITIATED | 713,100 | — | — | 1.88% | $58.5M | — |
As of 2025 Q4 — sorted by position size